All Publications from Accelerate Diagnostics

All Publications

Filter by:
Apr 16, 2019

Pathogen recovery from bronchoalveolar lavage specimens using an enhanced culture method as compared to standard of care testing
ECCMID 2019
Campeau S, Buchan B, Culbreath K, et al. (Accelerate Diagnostics Inc, Medical College of Wisconsin, Tricore Reference Laboratories, Indiana University School of Medicine)

Apr 16, 2019

Performance of Accelerate PhenoTest™ BC kit for Susceptibility Testing of Acinetobacter baumannii
ECCMID 2019
Towne J, Oppermann N, Humphries R, Doi Y (Accelerate Diagnostics, Inc, University of Pittsburgh School of Medicine)

Apr 16, 2019

Rapid identification and antimicrobial susceptibility testing of bacteria in bloodstream infections in paediatric patients using the time-lapse microscopy technology
ECCMID 2019
P. Bernaschi, B. Lucignano, M.T. D’Urbano, M. Agosta, A. Angelaccio, M. Argentieri, F. Bubola, F. Di Leva, L. Mancinelli, M. Onori, L. Pansani, A. Sisto, A. Onetti Muda (Bambino Gesù Childrens’ Hospital - IRCCS, Rome, Italy)

Apr 16, 2019

The benefits of quick microbial identification and antimicrobial susceptibility results for critically ill patients and antibiotics stewardship
ECCMID 2019
Houdini HT Wu, Steven Wilson, Li Xu-McCrae, Ahmed Hussain, Karen Reynolds, Abid Hussain (PHE, Public Health Laboratory, Birmingham)

Apr 16, 2019

Development of a diagnostic antibiotic stewardship strategy combining therapeutic drug monitoring with culture-independent fast antimicrobial susceptibility testing in patients suffering from pneumonia
ECCMID 2019
Matthias Karrasch, Sophie Neugebauer, Sibylle Bremer-Streck, Michael Kiehntopf (Jena University Hospital)

Feb 27, 2019

Evaluation of the Accelerate Pheno™ System for identification of Acinetobacter clinical isolates and minocycline susceptibility testing
Journal of Clinical Microbiology
Bowler et al. (University of Pittsburgh School of Medicine, Accelerate Diagnostics)

Jan 25, 2019

The hypothetical impact of Accelerate Pheno™ system on time to effective therapy and time to definitive therapy in an institution with an established antimicrobial stewardship programme currently utilizing rapid genotypic organism/resistance marker identification.
Journal of Antimicrobial Chemotherapy
Henig O, Cooper C, Kaye K, et al. (Detroit Medical Center)

Jan 25, 2019

Antimicrobial susceptibility testing of pathogens isolated from blood culture: a performance comparison of Accelerate Pheno™ and VITEK® 2 systems with the broth microdilution method.
Journal of Antimicrobial Chemotherapy
De Angelis G, Posteraro B, Menchinelli G, et al. (Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore)

Jan 25, 2019

Susceptibility Provision Enhances Effective De-escalation (SPEED): utilizing rapid phenotypic susceptibility testing in Gram-negative bloodstream infections and its potential clinical impact.
Journal of Antimicrobial Chemotherapy
Schneider J, Wood J, Schmitt B, et al. (Indiana University Health Pathology Laboratory, Indiana University Health Hospitals, Riley Hospital for Children)

Jan 16, 2019

Performance of the Accelerate Diagnostics Pheno™ system with resin-containing BacT/ALERT® Plus blood culture bottles
Diagnostic Microbiology and Infectious Disease
Starr et al. (Duke University Medical Center and University of Washington Medical Center)